These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 16236935)

  • 1. Reduced ejection fraction after myocardial infarction: is it sufficient to justify implantation of a defibrillator?
    Pascale P; Taffe P; Regamey C; Kappenberger L; Fromer M
    Chest; 2005 Oct; 128(4):2626-32. PubMed ID: 16236935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
    Moss AJ; Zareba W; Hall WJ; Klein H; Wilber DJ; Cannom DS; Daubert JP; Higgins SL; Brown MW; Andrews ML;
    N Engl J Med; 2002 Mar; 346(12):877-83. PubMed ID: 11907286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Acute Myocardial Infarction.
    Pokorney SD; Miller AL; Chen AY; Thomas L; Fonarow GC; de Lemos JA; Al-Khatib SM; Peterson ED; Wang TY
    JAMA; 2015 Jun 23-30; 313(24):2433-40. PubMed ID: 26103027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presumed arrhythmic death in consecutive survivors of acute myocardial infarction--implications for primary implantable cardioverter defibrillator implantation.
    Holmgren CM; Nyström BM; Karlsson TK; Herlitz JD; Edvardsson NG
    Coron Artery Dis; 2009 Mar; 20(2):155-62. PubMed ID: 19238081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reassessment of Cardiac Function and Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Myocardial Infarction.
    Pokorney SD; Miller AL; Chen AY; Thomas L; Fonarow GC; de Lemos JA; Al-Khatib SM; Velazquez EJ; Peterson ED; Wang TY
    Circulation; 2017 Jan; 135(1):38-47. PubMed ID: 27881561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of early risk stratification and targeted implantable cardioverter-defibrillator implantation after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Zaman S; Sivagangabalan G; Narayan A; Thiagalingam A; Ross DL; Kovoor P
    Circulation; 2009 Jul; 120(3):194-200. PubMed ID: 19581496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials?
    Coats AJ
    Int J Cardiol; 2002 Jan; 82(1):1-5. PubMed ID: 11786150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term arrhythmia-free survival in patients with severe left ventricular dysfunction and no inducible ventricular tachycardia after myocardial infarction.
    Zaman S; Narayan A; Thiagalingam A; Sivagangabalan G; Thomas S; Ross DL; Kovoor P
    Circulation; 2014 Feb; 129(8):848-54. PubMed ID: 24381209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiology-guided defibrillator implantation early after ST-elevation myocardial infarction.
    Kumar S; Sivagangabalan G; Zaman S; West EB; Narayan A; Thiagalingam A; Kovoor P
    Heart Rhythm; 2010 Nov; 7(11):1589-97. PubMed ID: 20650333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk stratification and survival in post myocardial infarction patients: a large prospective and multicenter study in Japan.
    Ohno J; Watanabe E; Toyama J; Kawamura T; Ohno M; Kodama I
    Int J Cardiol; 2004 Feb; 93(2-3):263-8. PubMed ID: 14975557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.
    Hohnloser SH; Kuck KH; Dorian P; Roberts RS; Hampton JR; Hatala R; Fain E; Gent M; Connolly SJ;
    N Engl J Med; 2004 Dec; 351(24):2481-8. PubMed ID: 15590950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes in patients with sustained ventricular tachyarrhythmias occurring within 48 h of acute myocardial infarction: when is ICD appropriate?
    Liang JJ; Hodge DO; Mehta RA; Russo AM; Prasad A; Cha YM
    Europace; 2014 Dec; 16(12):1759-66. PubMed ID: 25100756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time dependence of mortality risk and defibrillator benefit after myocardial infarction.
    Wilber DJ; Zareba W; Hall WJ; Brown MW; Lin AC; Andrews ML; Burke M; Moss AJ
    Circulation; 2004 Mar; 109(9):1082-4. PubMed ID: 14993128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in early and late mortality in patients undergoing coronary catheterization for myocardial infarction: implications on observation periods and risk factors to determine ICD candidacy.
    Bunch TJ; May HT; Bair TL; Crandall BG; Weiss JP; Osborn JS; Anderson JL; Muhlestein JB; Horne BD; Lappe DL; Day JD
    Heart Rhythm; 2011 Sep; 8(9):1460-6. PubMed ID: 21457792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
    Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
    J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased intra-QRS fragmentation in magnetocardiography as a predictor of arrhythmic events and mortality in patients with cardiac dysfunction after myocardial infarction.
    Korhonen P; Husa T; Tierala I; Väänänen H; Mäkijärvi M; Katila T; Toivonen L
    J Cardiovasc Electrophysiol; 2006 Apr; 17(4):396-401. PubMed ID: 16643362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors affecting the all-cause death and sudden cardiac death rates of post myocardial infarction patients with low left ventricular ejection fraction.
    Dai SM; Zhang S; Chen KP; Hua W; Wang FZ; Chen X
    Chin Med J (Engl); 2009 Apr; 122(7):802-6. PubMed ID: 19493393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk stratification for malignant arrhythmic events in patients with an acute myocardial infarction: role of an open infarct-related artery and the signal-averaged ECG.
    Hermosillo AG; Araya V; Casanova JM
    Coron Artery Dis; 1995 Dec; 6(12):973-83. PubMed ID: 8723020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimising the dichotomy limit for left ventricular ejection fraction in selecting patients for defibrillator therapy after myocardial infarction.
    Yap YG; Duong T; Bland JM; Malik M; Torp-Pedersen C; Køber L; Gallagher MM; Camm AJ
    Heart; 2007 Jul; 93(7):832-6. PubMed ID: 17237132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insufficient compliance with current implantable cardioverter defibrillator (ICD) therapy guidelines in post myocardial infarction patients is associated with increased mortality.
    Pertzov B; Novack V; Zahger D; Katz A; Amit G
    Int J Cardiol; 2013 Jun; 166(2):421-4. PubMed ID: 22100182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.